New test aims to predict deadly infections in vulnerable transplant patients
NCT ID NCT07379554
Summary
This study aims to develop a personalized immune score to predict which immunocompromised patients (like transplant recipients) are at highest risk for severe infections. Researchers will measure various immune cells and responses in 150 patients before or shortly after their transplant or chemotherapy. The goal is to create a tool that helps doctors monitor high-risk patients more closely and tailor their treatments to prevent serious infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fondazione IRCCS Policlinico San Matteo
RECRUITINGPavia, Lombardy, 27100, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.